Related Experiment Videos
Quantitative screening of clinical isolates for immunoglobulin A protease production
Abstract:
The production of immunoglobulin A (IgA) protease is a potentially useful marker in differentiating pathogenic from nonpathogenic species of clinical isolates; however, current quantitative assay methods are too tedious for routine application. A simple quantitative method was developed to screen clinical isolates for IgA protease production. This method is based on the specificity of reaction between IgA and alpha chain-specific antiserum in an immunochemistry analyzer (Beckman Instruments, Inc., Brea, Calif.). Colonies of IgA protease producers (Streptococcus sanguis, Streptococcus pneumoniae, Neisseria gonorrhoeae, Neisseria meningitidis, and Haemophilus influenzae) were picked from solid media, transferred to brain heart infusion containing IgA1, and incubated at 37 degrees C for at least 2 h to provide a detectable decrease in IgA concentration. The standard deviation for randomly picked colonies within a species was about +/- 15%. Several IgA protease-negative species caused no detectable reduction in the IgA content of the system. The specificity of the IgA measurement eliminates the requirements for extensive purification and radiolabeling of substrate and provides the basis for a well-defined IgA protease activity unit (micrograms of IgA1 cleaved per minute per milliliter of culture).
Insights
A new, simple quantitative assay effectively screens for immunoglobulin A (IgA) protease production in clinical isolates. This method aids in differentiating pathogenic from nonpathogenic bacterial species, improving diagnostic efficiency.
Area of Science:
- Microbiology
- Immunochemistry
- Clinical Diagnostics
Background:
- Immunoglobulin A (IgA) protease production is a key differentiator between pathogenic and nonpathogenic clinical isolates.
- Existing quantitative assays for IgA protease are too time-consuming for routine clinical use.
Purpose of the Study:
- To develop a simple, quantitative method for screening clinical isolates for IgA protease production.
- To establish a reliable assay for differentiating bacterial species based on IgA protease activity.
Main Methods:
- A novel immunochemical method utilizing an immunochemistry analyzer and alpha chain-specific antiserum was developed.
- Bacterial colonies were incubated with IgA1 in brain heart infusion, and IgA concentration decrease was measured.
- The method quantifies IgA protease activity based on the cleavage of IgA1.
Main Results:
- The assay demonstrated a standard deviation of approximately +/- 15% for randomly selected colonies within a species.
- Several IgA protease-negative species did not reduce IgA content, confirming assay specificity.
- The method provides a well-defined unit of IgA protease activity (µg IgA1 cleaved/min/mL culture).
Conclusions:
- This simple quantitative assay is suitable for routine screening of clinical isolates for IgA protease production.
- The method's specificity eliminates the need for complex substrate purification and radiolabeling.
- The assay facilitates the differentiation of pathogenic and nonpathogenic bacterial species.